From a somatic alteration standpoint, we found a decreased frequency of VHL mutations and 3p loss in patients with predominantly AFR genetic similarity relative to EUR genetic similarity, even when correcting for other potentially confounding clinical variables such as HTN and eGFR. This evidence concerns the gene VHL and hypertensive disorder.